APPENDIX I

ACCOUNTANTS’ REPORT

The following is the text of a report set out on pages I-1 to I-68, received from the
Company’s reporting accountants, Deloitte Touche Tohmatsu, Certified Public Accountants,
Hong Kong, for the purpose of incorporation in this prospectus.

ACCOUNTANTS’ REPORT ON HISTORICAL FINANCIAL INFORMATION

To the Directors of Innovent Biologics, Inc., Morgan Stanley Asia Limited, Goldman
Sachs (Asia) L.L.C., J.P. Morgan Securities (Far East) Limited and China Merchants
Securities (HK) Co., Limited

Introduction

We report on the historical financial

information of Innovent Biologics, Inc. (the
“Company”) and its subsidiaries (together, the “Group”) set out on pages I-5 to I-68, which
comprises the consolidated statements of financial position of the Group as at 31 December
2016 and 2017 and 30 June 2018, the statements of financial position of the Company as at 31
December 2016 and 2017 and 30 June 2018, and the consolidated statements of profit or loss
and other comprehensive income, the consolidated statements of changes in equity and the
consolidated statements of cash flows of the Group for each of the two years ended 31
December 2017 and the six months ended 30 June 2018 (the “Relevant Periods”) and a
summary of significant accounting policies and other explanatory information (together, the
“Historical Financial Information”). The Historical Financial Information set out on pages I-5
to I-68 forms an integral part of this report, which has been prepared for inclusion in the
prospectus of the Company dated 18 October 2018 (the “Prospectus”) in connection with the
initial listing of shares of the Company on the Main Board of The Stock Exchange of Hong
Kong Limited (the “Stock Exchange”).

Directors’ responsibility for the Historical Financial Information

The directors of the Company are responsible for the preparation of the Historical
Financial Information that gives a true and fair view in accordance with the basis of preparation
set out in note 2 to the Historical Financial Information, and for such internal control as the
directors of the Company determine is necessary to enable the preparation of the Historical
Financial Information that is free from material misstatement, whether due to fraud or error.

Reporting accountants’ responsibility

Our responsibility is to express an opinion on the Historical Financial Information and to
report our opinion to you. We conducted our work in accordance with Hong Kong Standard on
Investment Circular Reporting Engagements 200 “Accountants’ Reports on Historical
Financial Information in Investment Circulars” issued by the Hong Kong Institute of Certified
Public Accountants (the “HKICPA”). This standard requires that we comply with ethical
standards and plan and perform our work to obtain reasonable assurance about whether the
Historical Financial Information is free from material misstatement.

– I-1 –

